Best Small Molecule Podcasts (2025)

1
Allosteric small molecule therapies in PD, with Gene Mack 20:01

Play Pause

8d ago20:01

20:01

As Gain Therapeutics announces positive Phase 1b results for its lead compound, GT-02287, pharmaphorum looks back to a conversation with the company’s CEO Gene Mack earlier in the year, discussing allosteric small molecule therapies in the Parkinson’s disease space. Mack discusses the company’s progress in this field, and explores where next in ter…

1
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40 1:18:34

16d ago1:18:34

1:18:34

On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the European firm Azafaros. They chat about Azafaros’ massive $147M Series B round in May 2025, which is being used to develop a small molecule treatment for rare diseases known as lysosomal storage disorders.Stefano also explains how rare diseases went in and out of …

1
Smoothing a contract pathway through uncertainty: In conversation with Neal Masia 30:30

1d ago30:30

30:30

Back in June, pharmaphorum spoke with Entity Risk’s CEO and co-founder, Neal Masia, a leading health economist, about the unknowns unfolding in the US following the commencement of the second Trump administration this year. Tune into today’s podcast for an exploration of the potential scenarios Masia mused might arise, as well as his insights on th…

1
The Current: Discovering Chemistry's Zeitgeist- Flashback to Graduate School and the Central Dogma- Visual Lecture 24:21

1d ago24:21

24:21

The Current: Discovering Chemistry's Zeitgeist- Flashback to Graduate School and the Central Dogma- Visual Lecture --- Please note the views of this podcast represent those of my guest and I, and AI may have been used in the production of the episode. Please see a board-certified medical professional, that is state licensed for medical or professio…

1
A Celebration of Excellence with Diverse Leaders in Academia, Medicine, Engineering, Athletics & Public Service from Harvard, MIT, UC Davis, Georgia Tech, Princeton, The White House, and The Bahamas 10:31:54

3d ago10:31:54

10:31:54

A Celebration of Juneteenth with Leaders of Color in Academia, Medicine, Engineering and Athletics. Here is the complete list: Chancellor Gary May ( Chancellor of UC Davis), Dean Raheem Beyah (Dean, College of Engineering, Georgia Tech), Dr. Emery Brown, MD, PhD ( Anesthesiologist-Statistician, Harvard/ MIT/ Mass. General Hospital), Chase Griffin (…

1
"From BMES to the States: Excellence, Athletics, and Building Bridges Across Cultures"- A Conversation with Antonio Smith, A Longstanding Highschool Friend and Quality Control Leader 33:20

2d ago33:20

33:20

"From BMES to the States: Excellence, Athletics, and Building Bridges Across Cultures"- A Conversation with Antonio Smith, A Longstanding Highschool Friend and Quality Control Leader --- Episode Description: Join me for a cool conversation with one of my closest friends, Antonio Smith, as we dive deep into a journey that spans two countries, multip…

1
FH25: On the future of health, with Frontiers Health Chairman Roberto Ascione 12:44

3d ago12:44

12:44

In the final episode of our special Frontiers Health limited series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with the Chairman of Frontiers Health, Robert Ascione. Ascione - a serial entrepreneur & thought leader in health innovation and digital health, global executive, CEO and founder of Healthware Group, and President of Hea…

1
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored] 1:07:40

4d ago1:07:40

1:07:40

Hot on the heels of CUTISS’ $60M Series C round, we catch up once more with CEO and co-founder Daniela Marino. We chat about the company’s mission to develop an engineered tissue therapy to reduce the need for skin grafts in patients with severe burns. She also explains the decentralization of tissue manufacturing with automation and the need for p…

1
RNA Secrets Unveiled: Byron Purse's Biotech Breakthrough Journey 43:54

6d ago43:54

43:54

Send us a text In this episode of the Life Science Success Podcast my guest is Byron Purse, co-founder of AlidaBio and professor of chemistry at San Diego State University who is pioneering innovative approaches to studying RNA modifications. Byron brings a wealth of expertise in synthetic and natural nucleic acid modifications, with a passion for …

1
Mentorship in Motion: Five Years of Learning with A Leading Chemical Engineer Dr. Robert Langer—Guiding Science from Lab to World (2020-2025) 1:12:29

8d ago1:12:29

1:12:29

This curated compilation with leaders such as Dr. Etienne, and Dr. Langer, as well as early career professionals and students such as MD-PhD Student Chadwin Hanna, Dr. Ugo, Dr. Maada, and PharmD Student David Ferguson, stitches together the most resonant moments from four interviews recorded in 2020, 2023, 2024, and 2025 with Institute Professor Ro…

1
Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41 1:08:49

9d ago1:08:49

1:08:49

Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to chat about the company’s work with antibody-drug conjugates (ADCs).They talk about Araris’ huge $400M upfront buyout by Taiho Pharma of Japan, Dragan’s extensive history as a biotech entrepreneur, and Araris’ vision to replace chemotherapy with ADCs.⭐️ ABOUT THE S…

1
FH25: Jessica DaMassa on hosting, hype, and health innovation 29:41

9d ago29:41

29:41

As one of Frontiers Health’s most recognisable faces (and voices), Jessica DaMassa, founder of WTF Health and long-time emcee of the conference, has had a front-row seat to the events evolution over the last decade. In this episode of the pharmaphorum podcast’s special Frontiers Health anniversary series, DaMassa joins Deep Dive editor, Eloise McLe…

1
Improving ROI on AI investments and data quality, with Dr Jay Anders 17:12

10d ago17:12

17:12

Healthcare organisations are facing the simultaneous pressures of demonstrating ROI on AI investments, addressing clinician burnout, and satisfying compliance requirements. In a new pharmaphorum podcast, Dr Jay Anders, chief medical officer for Medicomp Systems, and also host of the Tell Me Where IT Hurts podcast, discusses why he believes that the…

1
The importance of being disruption ready, with Brandon Pence 19:36

15d ago19:36

19:36

The cell culture media industry is currently experiencing significant growth, driven by the increasing demand for biopharmaceuticals, advancements in tissue engineering, and the rising number of research activities in cell biology. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brandon Pence, who was recently appointed Preside…

1
The Riemann Key: Unlocking Modern Nobel Discoveries of the Past with a 19th-Century Thesis 1:40:33

14d ago1:40:33

1:40:33

The Riemann Key: Unlocking Modern Nobel Discoveries of the Past with a 19th-Century Thesis-- Please note the views of this podcast represent those of my guest and I, and AI may have been used in the production of the episode. Please see a board-certified medical professional, that is state licensed for medical or professional advice. We disclaim an…

1
FH25: Commercialising Health Tech and Deeptech, with Pilar Fernández Hermida 34:03

16d ago34:03

34:03

This year marks the 10th anniversary of Frontiers Health. In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy expert Pilar Fernández Hermida, founder of i-Expand, a commercial strategy firm focused on assisting Health Tech and Deeptech companies grow and monetise. Fernández Hermid…

1
Agentic AI, culture shifts, and commercialisation today: Anthony Cilento post-Axtria Ignite 2025 11:57

17d ago11:57

11:57

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Anthony Cilento, vice president, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI more generally. Cilento speaks to the advancement from GenAI to agentic AI, what’s changed for his own team in this regard and what’…

1
FH25: On patient access and equity, with Roberta Sarno 19:28

19d ago19:28

19:28

This year marks the 10th anniversary of Frontiers Health. In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor at D-Health Consulting, Roberta Sarno. Sarno is also director of the APAC Liver Disease Alliance, and consultant on digital health APAC policy at …

1
Revolutionizing Addiction Risk: Genetics, Tech, and Hope Unveiled 48:27

20d ago48:27

48:27

Send us a text In this episode of the Life Science Success Podcast my guest is James Piacentino, CEO of Thrive Genetics, Inc., a pioneering digital health startup focused on transforming addiction risk assessment through genetic and behavioral science. James brings a unique blend of entrepreneurial experience, technical expertise, and personal miss…

1
FH25: On healthcare innovation with Gary Monk 11:25

23d ago11:25

11:25

This year marks the 10th anniversary of Frontiers Health. In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with healthcare innovation consultant Gary Monk. Monk shares his favourite memory from the conference’s past decade, and discusses its ethos, as well as how his work at the moment aligns with that…

1
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39 58:02

23d ago58:02

58:02

We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI) specialist Insilico Medicine. Born in Latvia, Alex founded Insilico in 2014, with the company raising a huge $110M Series E round this year. Alex gives us a tour of Insilico’s sprawling pipeline, a blunt rundown of the competitive landscape in AI drug…

1
From Lab Bench to Bedside: Cardiolipin Science Saves Lives- The Significant Connection between D.J. Ferguson's Master's Thesis and Forzinity's Recent Approval 28:43

24d ago28:43

28:43

From Lab Bench to Bedside: Cardiolipin Science Saves Lives- The Significant Connection between D.J. Ferguson's Master's Thesis and Forzinity's Recent Approval ---- On September 19, 2025, the FDA granted accelerated approval to FORZINITY™ (elamipretide), a groundbreaking new drug for Barth syndrome—an ultra-rare genetic disorder affecting only about…

1
FH25: The art of connection at Frontiers Health with Aline Noizet 11:04

28d ago11:04

11:04

Frontiers Health marks its 10th anniversary this year, celebrating a decade of innovation, collaboration, and the connections that drive progress. In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Aline Noizet, founder of Digital Health Connector – a phrase that she says…

1
Policy in Focus: Trump’s Most Favoured Nations drug pricing scheme – with Alice Valder Curran 35:41

29d ago35:41

35:41

In Donald Trump's first presidential term, he spoke a lot about "Most Favoured Nations" pricing for pharmaceuticals - that is, bringing the prices that Americans pay for drugs in line with prices paid around the world. In his first term, all that talk didn't amount to much. But this time around the pharma industry is taking the President much more …

1
Financial Strategies for Life Science Startups: Insider Secrets Revealed! 54:52

29d ago54:52

54:52

Send us a text In this episode of the Life Science Success Podcast my guest is Josh Yelen, a CPA, MBA, and the Founder & CEO of Function, a strategic financial leadership and bookkeeping services company that supports businesses across various industries, including life sciences. With over two decades of experience in operations, accounting, financ…

1
FH25: Exploring the intersection of patients, HCPs, and technology with Denise Silber 12:54

1M ago12:54

12:54

Frontiers Health is back, and celebrating 10 years of innovation, conversation, and collaboration. In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Denise Silber, founder of Basil Strategies and Doctors 2.0. Having spent more than two decades working at the intersection…

1
The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host) 58:54

1M ago58:54

58:54

The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host) --- On The Path to KOLs from The New Chemist’s Podcasting Group, hosts David Ferguson and Chadwin Hanna explore how Latin America is becoming a strateg…

1
The New Chemist's Podcast Interview with Abhinaya Uthayakumar, BS, MEM- Associate Director, Project Leadership at Abbot (Former Colleague and BME Mentor at Georgia Tech) w/ Bossa Nova and the Top 300 2:33:59

1M ago2:33:59

2:33:59

Please note the views of this podcast do not constitute medical or professional advice, these serve an educational entertainment purpose only, and reflect the views of my guest and I. We disclaim any loss in any way. Please see a board and state certified health professional for medical advice, suggestions and consultation. --- The New Chemist's Po…

1
Doing good in people’s lives: Amy Burroughs discusses CML 10:39

1M ago10:39

10:39

Chronic myeloid leukaemia (CML) is a unique disorder in the rare disease sector because there are multiple approved therapies for patients and, in the US alone, the prevalence of CML is expected to triple by 2040. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Amy Burroughs, CEO of Terns Pharmaceuticals, about available treatm…

1
The Path to KOLs--Ukranian Episode: Шлях до KOL: Наука, Лідерство та Сила Малих Кроків (The Path to KOL: Science, Leadership, and the Power of Small Steps) 49:52

1M ago49:52

49:52

The Path to KOLs--Ukranian Episode: Шлях до KOL: Наука, Лідерство та Сила Малих Кроків (The Path to KOL: Science, Leadership, and the Power of Small Steps) -- До кожного, хто переживає складний період: пам’ятайте, що тіні є доказом існування світла. Коли шлях уперед незрозумілий, а тягар світу здається надто важким, тримайтеся за тиху силу, яка жив…

1
FH25: Individual centric investing with Steve Seuntjens 9:12

1M ago9:12

9:12

In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital. Seuntjens has long been focused on investing in innovation that puts the individual at the centre of health. For him, building companies is never easy – but it becomes meaningful w…

1
Pharma and health advertising: Brian Coane on the necessity of humour 17:17

1M ago17:17

17:17

When it comes to breaking down barriers, humour is vitally important, helping to do away with stigma when it comes – in particular – to pharma and health advertising. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Coane, health partner at creative agency Leith, who talks sensitivity, maximum impact, and overcoming the fe…

1
AI Edge Revolution: How Data Centres are Reshaping for AI Service Serving a Vertical Need | Emmanuel Becker 37:36

1M ago37:36

37:36

The data centre industry is experiencing unprecedented disruption. As AI applications drive explosive demand for computing power, traditional approaches to data centre design and deployment are becoming obsolete almost overnight. In this episode, Emmanuel Becker, CEO of Mediterra Datacenters, shares insights from his extensive career spanning the e…

1
Animated Series Remixed with an Insightful Interview- The New Chemist's Podcast- Interview with Dr. L.C. Campeau - Associate Vice President and Head of Small Molecule R&D at Merck 32:10

1M ago32:10

32:10

Animated Series Remixed with an Insightful Interview- The New Chemist's Podcast- Interview with Dr. L.C. Campeau - Associate Vice President and Head of Small Molecule R&D at Merck--- In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his a…

1
Pharma Water Expert Reveals Groundbreaking Innovation Strategies! 47:30

1M ago47:30

47:30

Send us a text In this episode of the Life Science Success Podcast my guest is Nissan Cohen, a worldwide expert with over 45 years of experience in high purity water systems, pharmaceutical engineering, and water technology innovation. Nissan is the Owner of Biopharmaceutical Water Doc company and has made significant contributions to the field thr…

1
The glimmer of opportunity behind the storm: Ali Pashazadeh talks biotech investment 26:11

1M ago26:11

26:11

Biotech finance has encountered what can arguably be termed the worst perfect storm in its history, and private investment in biopharma is in the midst of the longest drought. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with former surgeon and investment banker Ali Pashazadeh, CEO of Treehill, a strategic and financial advisory …

1
Climate Resilience in UK Housing: Preventing Overheating in Net Zero Homes | The Bryden Wood Podcast 49:12

1M ago49:12

49:12

The UK's push toward net zero has dramatically improved building insulation and airtightness. But there's an unintended consequence that could prove dangerous: overheating. As climate change brings more extreme heat to Britain, these highly insulated homes risk becoming dangerously hot without adequate cooling strategies. In this episode, co-founde…

1
FH25: The intersection of tech, science & design with Unity Stoakes 10:11

1M ago10:11

10:11

This year marks the 10th anniversary of Frontiers Health. In this episode of our Frontiers Health limited series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Unity Stoakes, president and co-founder of Startup Health and Advisory Board Member at The NeuroTech Collider Lab, University of California, Berkeley. Stoakes has spent 3…

1
Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38 58:22

2M ago58:22

58:22

We jet off to Central London to meet Robin Carr, CEO of Myricx Bio, a startup developing antibody-drug conjugates (ADCs) to treat cancer. The team’s idea – using a novel ADC payload inhibiting molecules called N-myristoyltransferases (NMTs) – helped them to bag an impressive £90M ($114M) Series A round in 2024. Robin outlines Myricx’s journey from …

1
Changing the drug development treatment paradigm: Hilary Eaton on AI and LLMs 23:33

2M ago23:33

23:33

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Hilary Eaton, a rare disease advocate and chief business officer at Profluent about AI-first protein design and its part in accelerating biomedicine. Eaton discusses her advocacy, gene editing, and how real-world evidence shows that AI scaling laws – which predict model performanc…

1
Revolutionizing Patient Recruitment in Clinical Trials | Victoria Donovan 33:21

2M ago33:21

33:21

Send us a text In this episode of the Life Science Success Podcast my guest is Victoria Donovan. Victoria is the Founder and CEO of Clinically Media, an award-winning agency that is transforming patient recruitment and retention strategies in clinical research. 00:00 Introduction to Life Science Success Podcast 00:38 Meet Victoria Donovan: Founder …

1
Remixed- The Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai 1:12:52

2M ago1:12:52

1:12:52

Remixed- Path to KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai ---In this episode we provide and educational episode remix made with software assistance ( for educational purposes only) , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to …

1
AI Meets RNA: Atomic AI's Revolutionary Drug Discovery Strategy 40:32

2M ago40:32

40:32

Send us a text In this episode of the Life Science Success Podcast my guest is Mark Stead, Head of Business Development at Atomic AI, a pioneering biotech company using artificial intelligence and structural biology to develop innovative RNA-targeted therapeutics. Mark brings over 12 years of experience in biotechnology, with a proven track record …

1
The Path to KOLs: Nobel Lecture Compendium (100+) with AI-Powered Overviews 1:25:57

2M ago1:25:57

1:25:57

The Path to KOLs: Nobel Lecture Compendium ( 100+) with AI-Powered Overviews In this episode, we compile over 100+ Nobel Lectures and key lectures and use AI LLMs to produce video overviews of those lectures. Please note: The views of this podcast represent those ofmy guest and I, and do not constitute medical, professional or financial advice or c…